Eliem Therapeutics Quote - ELYM

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

5.11

Bid

4.90

Offer

5.30

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

342.677M

Previous Close

5.11

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

67,060,163

Dividend Yield

PE Ratio

-9.76

Earnings Per Share (EPS)

-0.52

Revenue

Net Profit

-35.12M

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

climbbio.com

Headquarters

Wilmington, Delaware, USA

Founded

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ELYM - Frequently Asked Questions (FAQ)

What is the current Eliem Therapeutics share price?

The current share price of Eliem Therapeutics is US$ 5.11

How many Eliem Therapeutics shares are in issue?

Eliem Therapeutics has 67,060,163 shares in issue

What is the market cap of Eliem Therapeutics?

The market capitalisation of Eliem Therapeutics is USD 342.68M

What is the 1 year trading range for Eliem Therapeutics share price?

Eliem Therapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Eliem Therapeutics?

The price to earnings ratio of Eliem Therapeutics is -9.76

What is the reporting currency for Eliem Therapeutics?

Eliem Therapeutics reports financial results in USD

What is the latest annual profit for Eliem Therapeutics?

The latest annual profit of Eliem Therapeutics is USD -35.12M

What is the registered address of Eliem Therapeutics?

The registered address for Eliem Therapeutics is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808

What is the Eliem Therapeutics website address?

The website address for Eliem Therapeutics is climbbio.com

Which industry sector does Eliem Therapeutics operate in?

Eliem Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MSGMMotorsport Games Inc	US$ 2.69 (140.18%)	37M
SXTCChina SXT Pharmaceuticals Inc	US$ 2.11 (113.37%)	51.73M
ADGMAdagio Medical Holdings Inc	US$ 1.68 (81.98%)	115.48M
PNBKPatriot National Bancorp Inc	US$ 3.28 (73.54%)	1.57M
RTCBaijiayun Group Ltd	US$ 0.3601 (67.49%)	187.02M
LXEHLixiang Education Holding Company Ltd	US$ 8.25 (-64.11%)	1.55M
CLIKClick Holdings Ltd	US$ 0.355 (-48.18%)	13.52M
IOTRiOThree Ltd	US$ 1.1409 (-38.33%)	3.93M
FMTOFemto Technologies Inc	US$ 0.0191 (-35.47%)	198.4M
SISIShineco Inc	US$ 0.5809 (-35.07%)	824.91k
DMNDamon Inc	US$ 0.0034 (9.68%)	409.39M
STSSSharps Technology Inc	US$ 0.03195 (20.57%)	391.8M
SUNESUNation Energy Inc	US$ 0.0176 (-10.20%)	349.4M
NVDANVIDIA Corporation	US$ 101.49 (-2.87%)	292.48M
HTZHertz Global Holdings Inc	US$ 8.205 (43.70%)	266.91M